AdaptHealth (AHCO) Net Income towards Common Stockholders (2018 - 2026)

AdaptHealth's Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at -$14.9 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 143.19% year-over-year to -$14.9 million; the TTM figure through Mar 2026 stood at -$74.9 million (down 183.42% YoY), while the FY2025 annual figure was -$66.1 million, down 169.69% from the prior year.
• Net Income towards Common Stockholders was -$14.9 million for Q1 2026 at AdaptHealth, up from -$101.6 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $51.4 million in Q4 2024 to a low of -$452.9 million in Q3 2023.
• Historically, Net Income towards Common Stockholders has averaged -$36.7 million across 5 years, with a median of $12.8 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders soared 389.86% in 2022, then slumped 15381.01% in 2023.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$1.6 million in 2022, then plunged by 15381.01% to -$253.6 million in 2023, then jumped by 120.27% to $51.4 million in 2024, then slumped by 297.64% to -$101.6 million in 2025, then soared by 85.33% to -$14.9 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$14.9 million (Q1 2026), -$101.6 million (Q4 2025), and $25.8 million (Q3 2025), per Business Quant data.